Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00396292 · ClinicalTrials.gov registry record · Phase 3
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia
A Phase 3 study, sponsored by American Regent.
- Completed
- Registry status
- Phase 3
- Development phase
- 361
- Enrollment target
NCT00396292 is a Phase 3 study that has completed, run by American Regent. The registered enrollment target is 361 participants.
The verdict
NCT00396292, a Phase 3 study, has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 361 participants
- Enrollment target
Study Summary
This study compares the safety and efficacy of intravenous iron vs oral iron in subjects who display postpartum anemia.
Interventions
- DRUG VIT-45
- DRUG Oral iron tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2005-02 |
| Est. Completion | 2006-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00396292
The ClinicalTrials.gov registry entry for NCT00396292 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 361 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Regent, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VIT-45 is the first listed.
NCT00396292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00396292 about?
NCT00396292 is a clinical study titled "Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia". This study compares the safety and efficacy of intravenous iron vs oral iron in subjects who display postpartum anemia.
What is the current status of trial NCT00396292?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 361 participants. The study started on 2005-02. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00396292?
The interventions under investigation include: VIT-45 (DRUG), Oral iron tablets (DRUG).
Who is sponsoring clinical trial NCT00396292?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.